Physician profile
Mark Jorgensen
NPI 1407083710
$5,357.97
in general payments reported to CMS, 2019-2025
50 companies · $722 in 2025
The $722 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $495 · 2021: $641 · 2022: $859 · 2023: $915 · 2024: $1,060 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,696.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $940.82 | 2021-2025 | |
| Lilly USA, LLC | $702.98 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $522.95 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $349.27 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $325.78 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $201.64 | 2019-2024 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $178.37 | 2019-2025 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.82 | 2019-2025 | Jardiance |
| Abbott Laboratories | $167.68 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $134.35 | 2020-2024 | Gardasil, Gardasil 9, M-M-R II |
| Novo Nordisk INC | $123.15 | 2020-2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company Ltd. | $99.21 | 2022 | |
| Organon LLC | $94.03 | 2022-2025 | Nexplanon |
| Axsome Therapeutics, INC. | $92.35 | 2023-2025 | Auvelity, Sunosi |
| Amgen INC. | $88.39 | 2019-2022 |
Show all 49 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jorgensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.